Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
68,000
-200 (-0.29%)
At close: Sep 4, 2026
KRX:185750 Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, KRX:185750 stock has a consensus rating of "Buy" and an average price target of ₩102,857. The average 1-year stock price forecast is 51.26% higher than the current stock price, while the lowest is ₩80,000 (+17.65%) and the highest is ₩130,000 (+91.18%).
Price Target: ₩102,857 (+51.26%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for KRX:185750 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 7 | 7 |
Financial Forecast
Revenue This Year
1.89T
from 1.69T
Increased by 11.75%
Revenue Next Year
1.94T
from 1.89T
Increased by 2.51%
EPS This Year
5.10K
from 6.54K
Decreased by -22.12%
EPS Next Year
5.60K
from 5.10K
Increased by 9.89%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.